Juan C. Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, Inc. (CCXI), sold 12,205 shares at $13.97 ($170K) on 2013-03-06, disclosed to the SEC on 2013-03-06.
Scheduled sale ($170k) by SVP, Drug Discovery & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.96 | 5,008 | $70K | 41.0% |
| 2 | $13.97 | 2,950 | $41K | 24.2% |
| 3 | $13.97 | 4,247 | $59K | 34.8% |
| Total | $13.97 avg | 12,205 | $170K | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |